Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Ingrid Torrens"'
Autor:
Katrina Kostenko, Ingrid Torrens, Fedeline Camile, Melanie Freire, Regina M. Graham, Steven Vanni, Nicolas de Cordoba
Epidermal growth factor receptor (EGFR) is often overexpressed and/or mutated cancer. The most common mutation is EGFRvIII and has been found to correlate with tumor aggressiveness and poor outcome. In glioblastoma (GBM) expression of EGFRvIII is lin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cdfed4686ff3a59e1e6a73e40d1f3d72
https://europepmc.org/articles/PMC6012036/
https://europepmc.org/articles/PMC6012036/
Autor:
Sumedh S. Shah, Luis E. Raez, Katrina Kostenko, Jeffrey S. Prince, Winston M. Walters, Regina M. Graham, Steven Vanni, Frederic A. Vallejo, Ingrid Torrens, Ziad Khatib
Publikováno v:
Journal of Clinical Oncology. 37:e13558-e13558
e13558 Background: Glioblastoma (GBM) remains one of the most lethal primary brain tumors in children and adults. Despite enormous efforts to elucidate the genetic and epigenetic drivers of this disease, the prognosis for patients diagnosed with GBM
Autor:
Winston M. Walters, Eduardo A. Veliz, Stephan C. Schürer, Roger M. Leblanc, Lorenzo Sansalone, Regina M. Graham, Steven Vanni, Vasileios Stathias, Nadia G. Myrthil, Ingrid Torrens
Publikováno v:
Cancers, Vol 11, Iss 3, p 357 (2019)
Cancers
Volume 11
Issue 3
Cancers
Volume 11
Issue 3
Glioblastoma (GBM) has a dismal prognosis and successful elimination of GBM stem cells (GSCs) is a high-priority as these cells are responsible for tumor regrowth following therapy and ultimately patient relapse. Natural products and their derivative